HomeKYTX • NASDAQ
Kyverna Therapeutics Inc
add
$2.27
8.10%
After Hours:(0.00%)0.00
$2.27
Closed: May 23, 4:02:11 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.98M | 254.29% |
Net income | -44.64M | -268.37% |
Net profit margin | — | — |
Earnings per share | -1.03 | 8.04% |
EBITDA | -46.91M | -68.88% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 242.65M | -34.38% |
Total assets | 260.66M | -33.16% |
Total liabilities | 36.65M | 26.39% |
Total equity | 224.01M | — |
Shares outstanding | 43.22M | — |
Price to book | 0.48 | — |
Return on assets | -41.93% | — |
Return on capital | -46.87% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -44.64M | -268.37% |
Cash from operations | -44.92M | -75.96% |
Cash from investing | 5.58M | 104.54% |
Cash from financing | -414.00K | -100.12% |
Net change in cash | -39.75M | -120.96% |
Free cash flow | -27.47M | -63.17% |
Previous close
$2.47
Day range
$2.24 - $2.48
Year range
$1.78 - $16.64
Market cap
98.11M USD
Avg Volume
286.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
119
